Morgan's Scott Power highlights nine ASX healthcare companies from the 2025 Bioshares Biotech Summit with catalysts over next ...

The 60-year-old American spent three weeks in hospital suffering from hallucinations, paranoia and severe anxiety after ...

Psychedelics are increasingly being studied as wonder drugs for psychiatric issues like depression and addiction. Yet ...

Avant Technologies Inc. is an emerging technology company developing solutions in healthcare using artificial intelligence and biotechnologies. With a focus on pushing the boundaries of what is ...

Psychiatrist and board-certified addiction medicine physician Daniel Bober writes that modern cannabis, widely available and ...

Topline data from SERENITY At-Home Phase 3 trial for acute treatment of agitation associated with bipolar disorders or ...

New preclinical research in Neuropsychopharmacology focuses on the unique mechanism and site of action of evenamide as a ...

The tetrahydrocannabinol (THC) content of cannabis has roughly quintupled in the past 2 decades, from around 4% in the 2000s to more than 20% in most legal dried cannabis in Canada by 2023.[1][1] The ...

New findings in Neuropsychopharmacology - first to demonstrate that evenamide targets the key site of schizophrenia pathology ...

Following a tragic fire that killed chained inmates in a nearby facility, a Tamil Nadu dargah evolves a new model of mental ...

Mangosteen has garnered attention for its health benefits, namely its antioxidant and anti-inflammatory properties. It's ...